Kala Pharmaceuticals Inc. buy BiotechBee
Start price
21.07.25
/
70%
€5.11
Target price
27.06.27
€8.00
Performance (%)
224.39%
End price
28.09.25
€16.56
Summary
This prediction ended on 28.09.25 with a price of €16.56. With a performance of 224.39% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -25.821% | -25.821% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to BiotechBee what are the pros and cons of Kala Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kala Pharmaceuticals diskutieren
Buy mit Kursziel 8,0
In the thread Trading Kala Pharmaceuticals
Buy beendet
Stopped prediction by BiotechBee for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.56
28.09.25
28.09.25
€28.00
30.09.27
30.09.27
-93.39%
18.10.25
18.10.25
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.51
23.10.24
23.10.24
€6.50
28.02.27
28.02.27
5.26%
14.12.24
14.12.24
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.24
08.09.24
08.09.24
€8.00
30.04.27
30.04.27
5.25%
23.10.24
23.10.24
Could be very worthwhile Investment >20% year

